Krystal Biotech Inc (KRYS)
Debt-to-assets ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 1,055,840 | 982,318 | 917,658 | 853,296 | 818,355 | 790,350 | 684,026 | 531,847 | 558,450 | 576,379 | 601,324 | 616,874 | 626,295 | 451,095 | 443,556 | 443,018 | 310,844 | 311,451 | 318,145 | 205,131 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,055,840K
= 0.00
The debt-to-assets ratio for Krystal Biotech Inc has consistently been 0.00 for all reporting periods from March 31, 2020, to December 31, 2024. This indicates that the company has not used any debt financing to acquire assets during these periods. A debt-to-assets ratio of 0.00 implies that the company's assets are entirely funded by equity, which could suggest a lower financial risk profile and a strong financial position with no debt obligations to service. However, it is essential to consider other financial metrics and factors when evaluating the overall financial health and performance of Krystal Biotech Inc.
Peer comparison
Dec 31, 2024